🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Health X Platform Limited HEALTHX NSEPHARMA

Healthcare · Pharmaceutical Retailers · India
https://www.sastasundarventures.com
Company Profile ↓
₹300.30
+7.19% 1Y
Mkt Cap₹955.27 Cr
P/E-10.48
P/B1.52
52W High₹337.60
52W Low₹256.95
Book Value₹201.47
EPS (TTM)₹-28.66

Company Overview

Health X Platform Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services and Healthcare Network segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology and marketing of healthcare and OTC products through e-commerce portal. The company also provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services, as well as diagnostic services, including pathological/radiological investigation. In addition, it operates digital platforms for healthcare, including the Sastasundar app, a consumer-focused digital healthcare platform consisting of pharmacy, diagnostics, and wellness; and retailershakti.com, a B2B digital platform for pharmaceutical and wellness products. The company was formerly known as Sastasundar Ventures Limited Limited and changed its name to Health X Platform Limited in February 2026. Health X Platform Limited was incorporated in 1989 and is based in Kolkata, India.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 33.9% per year over the last five years.

Recent Developments

  • Mar 2026 Revenue of ₹1,307.65 Cr (+20.0% YoY); net profit ₹1.18 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +20.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.0%, profit CAGR 33.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.00%
1 Year:20.02%

Compounded Profit Growth

5 Years:33.88%
1 Year:-

Stock Price Performance

1 Year:+7.19%
6 Months:+11.04%
3 Months:+2.42%
1 Month:-2.78%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 54% of range
₹256.95 ₹337.60
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)49.33 · Neutral
Price Performance
1M-2.78%
3M+2.42%
6M+11.04%
1Y+7.19%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Profit CAGR of 33.9% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-10.48
Industry PE
41.64
Forward P/E
-
PEG Ratio
-
Book Value
₹201.47
Price to Book
1.52
P/S
0.71
EV/EBITDA
178.06
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
8.00%
Profit 5Y
33.88%
Revenue (YoY)
20.02%
Earnings (YoY)
-

Profitability & Returns

ROCE
-0.19%
ROE
0.18%
ROA
0.13%
Profit Margin
0.09%
Op Margin
-5.38%
Gross Margin
7.59%
EPS (Latest Qtr)
₹-3.51
EPS (TTM)
₹-28.66

Balance Sheet & Liquidity

Debt/Equity
4.00
Quick Ratio
0.63
Current Ratio
2.22
Debt
₹25.66 Cr
Total Assets
₹935.77 Cr
Current Assets
₹202.55 Cr
Working Capital
₹111.31 Cr

Ownership

Promoter Holding
79.86%
Chg in Prom Hold
0.14%
FII / Inst Holding
1.23%
Chg in FII Hold
-3.54%

Financial Snapshot

Enterprise Value
₹955.27 Cr
Total Revenue (TTM)
₹1,307.65 Cr
EBITDA
₹5.03 Cr
Free Cash Flow
₹-88.76 Cr
Operating Cash Flow
₹-73.83 Cr
Shares Outstanding
₹3.18 Cr
Gross Margin
7.59%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HEALTHX Health X Platform Limited NSEPHARMA 300.30 -10.48 ₹955.27 Cr 0.00% -0.19% 0.18% 8.00% 33.88%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,899.00 39.73 ₹4.56 L Cr 0.82% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,100.00 94.06 ₹2.42 L Cr 0.36% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,857.00 75.99 ₹1.64 L Cr 0.77% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,650.00 64.10 ₹1.24 L Cr 0.22% 19.20% 20.48% 14.85% 33.34%
6 LENSKART LENSKART SOLUTIONS LTD NIFTY_MIDNSEPHARMA 684.90 236.17 ₹1.19 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,120.00 22.36 ₹1.13 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,385.00 28.85 ₹1.12 L Cr 0.88% 14.86% 11.27% 7.23% 11.45%
9 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 1,840.00 111.85 ₹99,333.61 Cr 0.13% 19.53% 16.77% 3.77% 4.00%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 313.00 Cr336.00 Cr358.00 Cr374.00 Cr307.00 Cr270.00 Cr274.00 Cr-282.13 Cr278.74 Cr309.01 Cr341.52 Cr378.36 Cr
Cost of Revenue --------265.30 Cr257.60 Cr285.00 Cr315.21 Cr350.60 Cr
Gross Profit --------16.83 Cr21.14 Cr24.01 Cr26.30 Cr27.77 Cr
Operating Expenses 324.00 Cr327.00 Cr355.00 Cr371.00 Cr317.00 Cr273.00 Cr278.00 Cr-47.07 Cr35.94 Cr40.27 Cr43.05 Cr50.32 Cr
Operating Income -14.00 Cr7.00 Cr1.00 Cr1.00 Cr-14.00 Cr-4.00 Cr-6.00 Cr--30.24 Cr-14.80 Cr-16.26 Cr-16.75 Cr-22.55 Cr
EBITDA -11.00 Cr9.00 Cr3.00 Cr3.00 Cr-11.00 Cr-2.00 Cr-5.00 Cr--3.28 Cr31.44 Cr-17.27 Cr3.26 Cr-12.40 Cr
Interest Expense 0000000-1.30 L8.60 L3.79 L16.96 L48.82 L
Pretax Income -6.00 Cr19.00 Cr11.00 Cr21.00 Cr5.00 Cr25.00 Cr-174.00 Cr--4.63 Cr30.19 Cr-18.64 Cr91.87 L-14.83 Cr
Tax Provision -17.28 Cr-5.51 Cr-2.53 Cr84.00 L-29.15 Cr-25.75 Cr22.62 Cr--22.21 Cr3.59 Cr-3.20 Cr55.00 L-1.86 Cr
Net Income -48.00 Cr-0-12.00 Cr-3.00 Cr22.00 Cr41.00 Cr-155.00 Cr-13.67 Cr23.91 Cr-12.69 Cr1.13 Cr-11.17 Cr
Diluted EPS -10.750.41-2.55-0.245.179.79-34.39-4.307.52-3.990.35-3.51

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 52.00 Cr89.00 Cr135.00 Cr162.00 Cr222.00 Cr388.00 Cr551.00 Cr-1,038.19 Cr1,356.07 Cr1,089.53 Cr1,307.65 Cr
Cost of Revenue --------967.03 Cr1,232.78 Cr1,017.41 Cr1,208.40 Cr
Gross Profit --------71.15 Cr119.95 Cr72.12 Cr99.25 Cr
Operating Expenses 62.00 Cr116.00 Cr155.00 Cr175.00 Cr255.00 Cr440.00 Cr561.00 Cr-122.59 Cr142.92 Cr155.40 Cr169.58 Cr
Operating Income -16.00 Cr-35.00 Cr-27.00 Cr-19.00 Cr-39.00 Cr-57.00 Cr-14.00 Cr--51.44 Cr-22.96 Cr-83.28 Cr-70.33 Cr
EBITDA -10.00 Cr-28.00 Cr-20.00 Cr-13.00 Cr-33.00 Cr-52.00 Cr-10.00 Cr--113.19 Cr-20.35 Cr-186.81 Cr5.03 Cr
Interest Expense 1.00 Cr2.00 Cr3.00 Cr1.00 Cr3.00 Cr1.00 Cr3.00 Cr-86.76 L1.01 Cr21.72 L78.17 L
Pretax Income -15.00 Cr-37.00 Cr-28.00 Cr-12.00 Cr-42.00 Cr-58.00 Cr-16.00 Cr--122.25 Cr-30.50 Cr-192.86 Cr-2.36 Cr
Tax Provision 037.00 L-56.00 L-2.28 Cr-1.26 Cr5.22 Cr-64.00 L--22.78 Cr-36.35 Cr-70.12 Cr-91.03 L
Net Income -15.00 Cr-37.00 Cr-29.00 Cr-15.00 Cr-43.00 Cr-52.00 Cr-17.00 Cr--72.21 Cr8.88 Cr-91.17 Cr1.18 Cr
Diluted EPS -4.68-11.51-9.00-3.73-11.81-12.19-3.27197.04-22.702.79-28.66-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 281.00 Cr256.00 Cr251.00 Cr235.00 Cr230.00 Cr316.00 Cr293.00 Cr-1,205.82 Cr1,149.59 Cr974.37 Cr935.77 Cr
Current Assets --------486.21 Cr589.99 Cr579.61 Cr202.55 Cr
Cash & Equivalents --------31.72 Cr31.31 Cr12.42 Cr30.19 Cr
Inventory --------180.83 Cr115.79 Cr110.29 Cr144.65 Cr
Receivables --------35.08 Cr34.79 Cr9.98 Cr7.66 Cr
Total Liabilities --------212.26 Cr150.06 Cr109.84 Cr170.50 Cr
Current Liabilities --------89.18 Cr74.11 Cr98.02 Cr91.24 Cr
Long Term Debt -------0---22.09 Cr
Total Debt 5.00 Cr19.00 Cr21.00 Cr12.00 Cr2.00 Cr8.00 Cr12.00 Cr-9.33 Cr3.88 Cr91.90 L25.66 Cr
Total Equity 255.00 Cr218.00 Cr195.00 Cr176.00 Cr143.00 Cr210.00 Cr200.00 Cr-753.40 Cr762.37 Cr669.87 Cr640.89 Cr
Shares Outstanding --------3.18 Cr3.18 Cr3.18 Cr3.18 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -12.00 Cr-12.00 Cr-2.00 Cr-49.00 Cr-30.00 Cr-69.00 Cr-31.00 Cr--111.97 Cr35.86 Cr-17.31 Cr-73.83 Cr
Investing Cash Flow 7.00 Cr-1.00 Cr4.00 Cr15.00 Cr-2.00 Cr-22.00 Cr21.00 Cr-132.52 Cr-33.93 Cr-1.13 Cr171.19 Cr
Financing Cash Flow 4.00 Cr13.00 Cr5.00 Cr33.00 Cr26.00 Cr103.00 Cr4.00 Cr--1.83 Cr-2.35 Cr-44.31 L-79.59 Cr
Capital Expenditure -16.00 Cr-6.00 Cr2.00 Cr-6.00 Cr-3.00 Cr-2.00 Cr0--19.49 Cr-14.23 Cr-10.36 Cr-14.93 Cr
Free Cash Flow -28.00 Cr-18.00 Cr-0-55.00 Cr-33.00 Cr-71.00 Cr-31.00 Cr--131.46 Cr21.63 Cr-27.67 Cr-88.76 Cr
Net Change in Cash -1.00 Cr-07.00 Cr-2.00 Cr-6.00 Cr11.00 Cr-5.00 Cr-18.72 Cr-41.41 L-18.89 Cr17.77 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------6.9%8.8%6.6%7.6%
Operating Margin % -30.8%-39.3%-20.0%-11.7%-17.6%-14.7%-2.5%--5.0%-1.7%-7.6%-5.4%
Net Margin % -28.8%-41.6%-21.5%-9.3%-19.4%-13.4%-3.1%--7.0%0.7%-8.4%0.1%
ROE % -5.9%-17.0%-14.9%-8.5%-30.1%-24.8%-8.5%--9.6%1.2%-13.6%0.2%
ROCE % ---------4.6%-2.1%-9.5%-8.3%

Shareholding Pattern

Insiders
79.86%
Institutions
1.23%
Public Float
6.11%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HEALTHX

Google News hu, 30 Apr 2026

HEALTHX Stock Price and Chart — NSE:HEALTHX - TradingView

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1yc2V3MzYzR2V1eklab0dHZ0lXNndMQkN6Vk5JZU4waF9weHNlaDhydG5kVTdYMVpWZV9QbE9LSlp6TnNNeVBxWloxMy1IejJsV3I0S1ZsSDR2V05i?oc=5" target="_blank">HEALTHX Stock Price and Chart — NSE:HEALTHX…

Google News ue, 07 Apr 2026

Women’s HealthX brings together leading pharma innovators advancing the future of women’s healthcare - FemTech World

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN0VheEpOTHo4WTUyNldZTVFwZUY3RmJWZVlPbGVWTmdkamdKTW54Z0otdEVnQlJtb2hGQUplMlc3Sk53NktkT3BaLVpSX1BuN3ctZm5LVHI3RjhtWHFqX2FRdHVSUklWYkxNZTFXQUZmbEZpc3hDbXkza1dhdmRfbElEYnlpYU5Va2lYZE…

Google News Fri, 04 Sep 2026

Health X Platform files FY26 BRSR with BSE and NSE exchanges - scanx.trade

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPVjc0Z2dlQ1Y1Vzk0QU9PSGt1X2liLVpBQUtsaG5mVDczbzdGT0pGNkFLSFg5ZmUxX2hkc1phTElDdTZsUGFZVzduVlM4UUhUcExYeHN1T1FUTmJIMFlnTlA3bFNZdXBUZDM2em5WeWY4aUxUMkhhUHRSSEczMlhzWnpJRzdfcGlINWdZbj…

Google News Sat, 29 Aug 2026

HEALTHX Jun 2026 Earnings: Loss at ₹0.16 per Share on ₹0.08 Cr Revenue; Stock Up 2.21% - Earnings Surprise Report - siam.in

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPc2hXVTdZcDg0THpKWlMyMTdWMmxPdVRsV0lpZFN0TC1yUFlVcGtleG9lbFhfd082b0VraTJTR0NzQnNxb1EtMEx2X1VhU0JldUVSd3AxeWlBajVaSEswamFXa1ZrbElVLWJiOFpiUmUzWTBVaFh2UVdCVkFrQS1OMVVFVVg4SkNnTWswTE…

Google News Sun, 14 Jun 2026

HEALTHX Q4 FY2026 Earnings: Narrowing Losses on Minimal Revenue Base - Revenue Guidance Range - vinanet.vn

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxONkVHV25NdlJWbngxSUlGbUZLX0FmN3dmTndlS1hLeVJ6YUxoYjhDRUdfbEo4TjUzWTZ4TURoeG1EOFNLLXA5S3FIMWxpbXFVREVWZWhxLVdqR3F2NFdObXQ3aExQeWdVc0FoWlJzb1FOTmtzc2NhZnJuMzdoal8zZlN0NGlqaDJfQVBIaU…

Google News Fri, 04 Sep 2026

Health X Platform AGM seeks approval for ₹500 crore borrowing limit - scanx.trade

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNVVY3RU9LR0E4NWhWZ0s2WHM1X09zdXVZeVpvdmtmOTJVWHhXa0ZGUElPUnhLQXpiY0NhXzlaT1pNdkNaZVdaUFZCTXphVG04WndnM3IzMG05NVhsYXlPU3laU1FfY2JZQU5Qa3JwaUhhbk5Ca05qdFcwZUN0X3Z1a2dPWlVMcW92VHFkMk…

HEALTHX — Frequently Asked Questions

What is the current share price of Health X Platform Limited (HEALTHX)?

As of 2026-09-08 04:53 IST, Health X Platform Limited (HEALTHX) trades at ₹300.30 on NSE. Its 52-week range is ₹256.95 to ₹337.60.

What is the market capitalisation of HEALTHX?

Health X Platform Limited (HEALTHX) has a market capitalisation of ₹955.27 Cr on NSE.

What is the P/E ratio of HEALTHX?

HEALTHX trades at a trailing price-to-earnings (P/E) ratio of -10.48. The industry average P/E is 41.64. Its price-to-book (P/B) ratio is 1.52.

What is the return on equity (ROE) of HEALTHX?

HEALTHX has a return on equity (ROE) of 0.18%. Its return on capital employed (ROCE) is -0.19%.

Is HEALTHX a good stock to buy?

This page provides a data-driven analysis of Health X Platform Limited (HEALTHX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space